Sunday, November 28, 2021

NEWS

Cuba’s drug Nimotuzumab is highly effective against Covid-19

Cuba, Covid-19, fármaco, Nimotuzumab

Cuba’s drug Nimotuzumab is highly effective against Covid-19

Havana, Nov 8 (Prensa Latina) Cuba's drug Nimotuzumab has demonstrated its effectiveness and safety in severe and moderate Covid-19 patients, local media reported.
Share on facebook
Share on twitter
Share on whatsapp
Share on telegram
Share on email

According to Tania Crombet, director of Clinical Research at the Center for Molecular Immunology, the studies with the monoclonal antibody CIMAher® revealed an improvement in ventilation function and a reduction in the interleukin-6 (IL-6) concentration.

“Interleukin-6 is one of the main cytokines accounting for the hyperinflammatory state seen in SARS-CoV-2 patients,” the doctor said.

Eighty percent of patients presented a radiological improvement or stabilization in the multifocal interstitial lung disease on the seventh day after the first dose of Nimotuzumab was administrated, the specialist told Granma newspaper.

Likewise, preliminary evidence of prevention or reversion of fibrotic lesions could be observed by computerized axial tomography scan, reducing pulmonary sequelae, Crombet stated.

Nimotuzumab received its health registration in 2002 to treat head and neck tumors at advanced stages. It has proven that it blocks or inhibits the epidermal growth factor receptor, a highly validated target in oncology.

jg/iff/msm/joe

RELATED
ÚLTIMO MINUTO
name of Prensa Latina

| Text SMS to 8100 with content PL
Receive 4 mesages x 25 cup

© 2016-2021 Prensa Latina
Latin American News Agency

Radio – Publications  – Videos – News by the minute.
All Rigts Reserved.

St. E No 454 , Vedado,  Habana, Cuba.
Phones: (+53) 7 838 3496, (+53) 7 838 3497, (+53) 7 838 3498, (+53) 7 838 3499
Prensa Latina © 2021 .

Web Site developed by IT Division  Prensa Latina.